Welcome to our dedicated page for ALCHEMY INVTS ACQUISITN 1 SEC filings (Ticker: ALCY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alchemy Investments Acquisition Corp 1 filings document the regulatory record of a Cayman Islands blank-check company with Nasdaq-listed units, Class A ordinary shares and redeemable warrants. The disclosures describe the SPAC security structure, including units composed of one Class A ordinary share and one-half of one warrant, and warrants exercisable for Class A ordinary shares at a stated exercise price.
Its SEC record includes Form 8-K material-event reports, written communications, shareholder voting matters, material agreements, governance disclosures, capital-structure updates and operating and financial results. The filings also include reporting-status items such as a Form 12b-25 notification for an annual report and exchange-listing compliance disclosure.
Alchemy Investments Acquisition Corp 1 reported a Q1 2026 net loss of $331,900 as it continues to search for a target and close its announced merger with Cartiga.
The SPAC held $8.96 million in its Trust Account and only $86,243 in cash outside the trust, resulting in a working capital deficit of $3.91 million and substantial doubt about its ability to continue as a going concern without completing a deal.
Alchemy has a Business Combination Agreement to acquire Cartiga at an equity value of $540 million using an Up‑C structure, with closing conditioned on shareholder approvals, a Nasdaq listing and at least $40 million of available closing cash unless waived. Sponsor loans totaled $2.0 million and the company continues making monthly deposits to extend its deadline to complete a transaction to September 9, 2026.
Alchemy Investments Acquisition Corp 1 notified the SEC that it cannot file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 "without unreasonable effort or expense."
The company states it is working diligently and expects to file the Quarterly Report within five calendar days of the prescribed due date. The notification is signed by CEO Mattia Tomba and the filing includes SEC file number 001-41139.
Alchemy Investments Acquisition Corp 1 received a Nasdaq notice that it failed to comply with IM-5101-2 because it did not complete a business combination within 36 months of its IPO registration statement effective May 4, 2023. The Company will not appeal Nasdaq's determination and its Nasdaq trading will be suspended at the opening of business on May 14, 2026; the Company expects its securities to commence trading on the over-the-counter market on May 14, 2026.
Alchemy Investments Acquisition Corp 1, a special purpose acquisition company, reported that Nasdaq has determined its securities are subject to delisting for failing to comply with Nasdaq IM-5101-2. The rule requires a business combination within 36 months of the IPO registration statement, which became effective on May 4, 2023.
Because Alchemy did not complete an initial business combination by May 4, 2026, Nasdaq will suspend trading of its securities on May 14, 2026 and file Form 25-NSE to remove them from listing. The company will not appeal and expects its securities to begin trading on the over-the-counter market on May 14, 2026.
Alchemy Investments Acquisition Corp 1 filed an amended annual report to correct the date of a prior Marcum LLP audit opinion, while re-presenting its full 2025 financial statements and SPAC disclosures.
For 2025, the SPAC reported a net loss of $1.1 million versus prior-year profit of $4.2 million, with $8.8 million held in its trust account and only $55,020 of cash outside the trust. Auditors included a going concern paragraph, citing a $3.4 million working capital deficit and reliance on completing a business combination by September 9, 2026.
The filing details a proposed Business Combination Agreement with Cartiga, LLC, valuing Cartiga at $540 million and using an Up‑C structure in which Pubco (to be renamed Cartiga Holdings, Inc.) will be the public parent and Cartiga will remain the operating partnership. Closing conditions include at least $40 million of “Available Closing Buyer Cash,” Nasdaq listing approval, and multiple shareholder and member votes. Extensive ancillary agreements, including lock‑ups, a tax receivable agreement and a shareholders agreement granting significant governance rights to key investors, would govern the post‑closing structure.
Alchemy Investments Acquisition Corp 1 is a Cayman Islands blank check company that has not begun operations or generated revenue and is seeking an initial business combination, focusing on deep technology and data analytics sectors.
On August 22, 2025, it signed a Business Combination Agreement with Cartiga, LLC, though there is no assurance the deal will close. Shareholders approved extensions allowing completion of a business combination up to September 9, 2026, funded by monthly deposits into the trust account.
Large redemptions in 2024 and 2025 reduced the public float and trust balance, leaving approximately $8,813,038 in the trust account as of December 31, 2025 and 4,208,042 Class A and 1 Class B ordinary share outstanding as of April 8, 2026. If no business combination is completed by the deadline, public shares will be redeemed, with an expected per-share redemption around $10.15, and the SPAC will liquidate.
Alchemy Investments Acquisition Corp 1 disclosed an Investor Presentation dated April 2026 in connection with a proposed business combination with Cartiga, LLC. The filing states Alchemy intends to file a Registration Statement on Form S-4 including a preliminary proxy statement/prospectus and, when available, a definitive proxy statement and final prospectus.
The presentation is furnished under Regulation FD and will be used in investor presentations; the parties caution that the materials contain forward-looking statements and that completion of the transaction is subject to conditions including shareholder and regulatory approvals.
Alchemy Investments Acquisition Corp 1 filed an 8-K announcing an Investor Presentation prepared with Cartiga, LLC about their potential business combination. The April 2026 presentation, attached as Exhibit 99.1, is being used to brief investors on the proposed transaction.
The filing explains that Alchemy Acquisition Holdings, Inc. intends to submit a Registration Statement on Form S-4 to the SEC, including a preliminary proxy statement/prospectus for the proposed deal. Alchemy plans to mail a definitive proxy statement and proxy card to shareholders for an Extraordinary Meeting once available.
The document includes extensive forward-looking statement and risk disclosures, highlighting uncertainties around closing the business combination, required approvals, Nasdaq listing, redemption levels and Cartiga’s growth. It clarifies that the Investor Presentation is not an offer to sell securities or a solicitation to buy or vote, and that any securities offering would only occur through a compliant prospectus or exemption.
Alchemy Investments Acquisition Corp notified the SEC that it cannot file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 by the prescribed due date. The company states it is unable to file "without unreasonable effort or expense" and expects to file the Annual Report within fifteen calendar days of the prescribed due date. The filing was signed by Mattia Tomba, Chief Executive Officer, on April 1, 2026.
Alchemy Investments Acquisition Corp 1 disclosed that it and Cartiga, LLC are evaluating a potential private investment in public equity (PIPE) to support their proposed business combination. The companies stated no definitive PIPE agreements have been entered into and there is no assurance any PIPE will be consummated.
The filing notes Alchemy Acquisition Holdings, Inc. intends to file a Registration Statement on Form S-4 that will include a preliminary proxy statement/prospectus and, when available, a definitive proxy statement and final prospectus relating to the proposed business combination.